ACCELEWARE LTD (AXE.CA)

CA00433V1085 - Common Stock

0.11  +0.01 (+4.76%)

Fundamental Rating

2

AXE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 68 industry peers in the Software industry. AXE may be in some trouble as it scores bad on both profitability and health. AXE has a valuation in line with the averages, but on the other hand it scores bad on growth.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

AXE had positive earnings in the past year.
In the past year AXE had a positive cash flow from operations.
AXE had negative earnings in each of the past 5 years.
AXE had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

AXE has a better Return On Assets (276.92%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 276.92%
ROE N/A
ROIC N/A
ROA(3y)-138.34%
ROA(5y)-98.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AXE has a Profit Margin of 52.65%. This is amongst the best in the industry. AXE outperforms 100.00% of its industry peers.
The Operating Margin of AXE (71.41%) is better than 100.00% of its industry peers.
AXE has a Gross Margin of 8.31%. This is in the lower half of the industry: AXE underperforms 72.31% of its industry peers.
AXE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 71.41%
PM (TTM) 52.65%
GM 8.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y0.32%

More info and screens

1

2. Health

2.1 Basic Checks

AXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXE has more shares outstanding
AXE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXE has a worse debt to assets ratio.

2.2 Solvency

AXE has an Altman-Z score of -74.88. This is a bad value and indicates that AXE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -74.88, AXE is not doing good in the industry: 90.77% of the companies in the same industry are doing better.
AXE has a debt to FCF ratio of 2.76. This is a good value and a sign of high solvency as AXE would need 2.76 years to pay back of all of its debts.
AXE has a better Debt to FCF ratio (2.76) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.76
Altman-Z -74.88
ROIC/WACCN/A
WACC10.59%

2.3 Liquidity

A Current Ratio of 0.18 indicates that AXE may have some problems paying its short term obligations.
The Current ratio of AXE (0.18) is worse than 87.69% of its industry peers.
A Quick Ratio of 0.18 indicates that AXE may have some problems paying its short term obligations.
AXE has a worse Quick ratio (0.18) than 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18

More info and screens

2

3. Growth

3.1 Past

AXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.80%, which is quite impressive.
Looking at the last year, AXE shows a very strong growth in Revenue. The Revenue has grown by 988.71%.
AXE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -42.18% yearly.
EPS 1Y (TTM)142.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.48%
Revenue 1Y (TTM)988.71%
Revenue growth 3Y-32.3%
Revenue growth 5Y-42.18%
Sales Q2Q%1915.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.00, the valuation of AXE can be described as reasonable.
Based on the Price/Earnings ratio, AXE is valued cheaper than 93.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. AXE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXE is valued cheaply inside the industry as 90.77% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AXE is valued cheaply inside the industry as 81.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.67
EV/EBITDA 5.94

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCELEWARE LTD

TSX-V:AXE (1/7/2025, 7:00:00 PM)

0.11

+0.01 (+4.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-20 2024-11-20
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.85%
Ins Owner ChangeN/A
Market Cap13.03M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11
Fwd PE N/A
P/S 3.88
P/FCF 12.67
P/OCF 12.67
P/B N/A
P/tB N/A
EV/EBITDA 5.94
EPS(TTM)0.01
EY9.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY7.89%
OCF(TTM)0.01
OCFY7.89%
SpS0.03
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 276.92%
ROE N/A
ROCE -95.97%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 71.41%
PM (TTM) 52.65%
GM 8.31%
FCFM 30.63%
ROA(3y)-138.34%
ROA(5y)-98.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y0.32%
F-Score4
Asset Turnover5.26
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.76
Debt/EBITDA 1.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 42.36%
Profit Quality 58.17%
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z -74.88
F-Score4
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)988.71%
Revenue growth 3Y-32.3%
Revenue growth 5Y-42.18%
Sales Q2Q%1915.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y166%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.02%
OCF growth 3YN/A
OCF growth 5YN/A